Exploring the potential of newly synthesized 4-methyl-6-morpholino-pyrimidine derivatives as antiproliferative agents
作者:Supreet Gaonkar、Mohammed Azharuddin Savanur、Manjunath G. Sunagar、Bijesh Puthusseri、Narahari Deshapande、Afra A. Nadaf、Imtiyaz Ahmed M. Khazi
DOI:10.1039/c7nj04157h
日期:——
In view of exploring the potential of pyrimidine derivatives as anticancer agents, a series of 4-methyl-6-morpholinopyrimidine derivatives was synthesised and characterised by NMR (1H & 13C), SC-XRD and mass spectral analysis. The in vitro anticancer activity of these compounds was investigated using different human cancer cell lines, namely HeLa (cervix), NCI-H460 (lung), MCF-7 (breast), HepG2 (liver)
考虑到探索嘧啶衍生物作为抗癌剂的潜力,合成了一系列4-甲基-6-吗啉代嘧啶衍生物,并通过NMR(1 H&13 C),SC-XRD和质谱分析对其进行了表征。在体外用不同的人癌症细胞系的这些化合物的抗癌活性进行了研究,即HeLa细胞(子宫颈),NCI-H460(肺),MCF-7(乳腺),HepG2细胞(肝)和IMR-32(脑)。与其他衍生物相比,化合物4c和5h以剂量依赖的方式表现出有效的抗癌活性,在HeLa和NCI-H460细胞上的IC 50值分别为5.88±1.22和6.11±2.12μM。4c的抑制作用二倍体(subG1)群体,早期凋亡细胞群体,caspase-3 / 7活性的增加证明,癌细胞上的第5h和第5h增殖是活性氧(ROS)生成和随后诱导细胞凋亡的结果。 ,线粒体膜电位的丧失和核DNA的降解。此外,分子对接研究表明4c和5h化合物与雷帕霉素(mTOR)哺乳动物靶标的ATP结合袋结